313 related articles for article (PubMed ID: 11929048)
21. Pyridoxine refractory X-linked sideroblastic anemia caused by a point mutation in the erythroid 5-aminolevulinate synthase gene.
Furuyama K; Fujita H; Nagai T; Yomogida K; Munakata H; Kondo M; Kimura A; Kuramoto A; Hayashi N; Yamamoto M
Blood; 1997 Jul; 90(2):822-30. PubMed ID: 9226183
[TBL] [Abstract][Full Text] [Related]
22. [Familial pyridoxine-responsive sideroblastic anaemia. One case (author's transl)].
Garbarz M; Bernard JF; Boivin P
Nouv Presse Med; 1980 Nov; 9(44):3345-7. PubMed ID: 7443486
[TBL] [Abstract][Full Text] [Related]
23. X-linked sideroblastic anemia due to carboxyl-terminal ALAS2 mutations that cause loss of binding to the β-subunit of succinyl-CoA synthetase (SUCLA2).
Bishop DF; Tchaikovskii V; Hoffbrand AV; Fraser ME; Margolis S
J Biol Chem; 2012 Aug; 287(34):28943-55. PubMed ID: 22740690
[TBL] [Abstract][Full Text] [Related]
24. A novel mutation, Ile289Thr, in the ALAS2 gene in a family with pyridoxine responsive sideroblastic anaemia.
Percy MJ; Cuthbert RJ; May A; McMullin MF
J Clin Pathol; 2006 Sep; 59(9):1002. PubMed ID: 16935983
[No Abstract] [Full Text] [Related]
25. [Sideroblastic anemia].
Kondo M; Yano Y
Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):158-60. PubMed ID: 9645032
[No Abstract] [Full Text] [Related]
26. A Novel
Lee JS; Gu J; Yoo HJ; Koh Y; Kim HK
Ann Clin Lab Sci; 2017 May; 47(3):319-322. PubMed ID: 28667034
[TBL] [Abstract][Full Text] [Related]
27. Molecular defects of erythroid 5-aminolevulinate synthase in X-linked sideroblastic anemia.
Bottomley SS; May BK; Cox TC; Cotter PD; Bishop DF
J Bioenerg Biomembr; 1995 Apr; 27(2):161-8. PubMed ID: 7592563
[TBL] [Abstract][Full Text] [Related]
28. R411C mutation of the ALAS2 gene encodes a pyridoxine-responsive enzyme with low activity.
Furuyama K; Uno R; Urabe A; Hayashi N; Fujita H; Kondo M; Sassa S; Yamamoto M
Br J Haematol; 1998 Dec; 103(3):839-41. PubMed ID: 9858242
[TBL] [Abstract][Full Text] [Related]
29. [A novel mutation of the ALAS2 gene in a family with X-linked sideroblastic anemia].
Zhu P; Bu D
Zhonghua Xue Ye Xue Za Zhi; 2000 Sep; 21(9):478-81. PubMed ID: 11877024
[TBL] [Abstract][Full Text] [Related]
30. [A family of hereditary refractory sideroblastic anemia with markedly reduced delta-aminolevulinic acid synthetase activity in bone marrow erythroblasts].
Hirabayashi N; Utsumi M; Nakashima I; Yasuma A; Aoki N
Rinsho Ketsueki; 1976 Jan; 17(1):45-50. PubMed ID: 987283
[No Abstract] [Full Text] [Related]
31. Late-onset X-linked sideroblastic anemia following hemodialysis.
Furuyama K; Harigae H; Kinoshita C; Shimada T; Miyaoka K; Kanda C; Maruyama Y; Shibahara S; Sassa S
Blood; 2003 Jun; 101(11):4623-4. PubMed ID: 12531813
[TBL] [Abstract][Full Text] [Related]
32. Microcytic anemia in a pregnant woman: beyond iron deficiency.
Rollón N; Fernández-Jiménez MC; Moreno-Carralero MI; Murga-Fernández MJ; Morán-Jiménez MJ
Int J Hematol; 2015 May; 101(5):514-9. PubMed ID: 25547425
[TBL] [Abstract][Full Text] [Related]
33. Sideroblastic anaemia. A review of seven paediatric cases.
Hamel BC; Schretlen ED
Eur J Pediatr; 1982 Mar; 138(2):130-5. PubMed ID: 7094932
[TBL] [Abstract][Full Text] [Related]
34. [Recent progress in iron metabolism and iron-related anemia].
Harigae H
Rinsho Byori; 2010 Dec; 58(12):1211-8. PubMed ID: 21348241
[TBL] [Abstract][Full Text] [Related]
35. delta-Aminolevulinic acid synthetase in erythroblasts of patients with pyridoxine-responsive anemia. Hypercatabolism caused by the increased susceptibility to the controlling protease.
Aoki Y; Muranaka S; Nakabayashi K; Ueda Y
J Clin Invest; 1979 Nov; 64(5):1196-203. PubMed ID: 500806
[TBL] [Abstract][Full Text] [Related]
36. Regulation and tissue-specific expression of δ-aminolevulinic acid synthases in non-syndromic sideroblastic anemias and porphyrias.
Peoc'h K; Nicolas G; Schmitt C; Mirmiran A; Daher R; Lefebvre T; Gouya L; Karim Z; Puy H
Mol Genet Metab; 2019 Nov; 128(3):190-197. PubMed ID: 30737140
[TBL] [Abstract][Full Text] [Related]
37. Molecular regulation of 5-aminolevulinate synthase. Diseases related to heme biosynthesis.
May BK; Bhasker CR; Bawden MJ; Cox TC
Mol Biol Med; 1990 Oct; 7(5):405-21. PubMed ID: 2095458
[TBL] [Abstract][Full Text] [Related]
38. Molecular pathophysiology and genetic mutations in congenital sideroblastic anemia.
Fujiwara T; Harigae H
Free Radic Biol Med; 2019 Mar; 133():179-185. PubMed ID: 30098397
[TBL] [Abstract][Full Text] [Related]
39. Enzymatic defect in "X-linked" sideroblastic anemia: molecular evidence for erythroid delta-aminolevulinate synthase deficiency.
Cotter PD; Baumann M; Bishop DF
Proc Natl Acad Sci U S A; 1992 May; 89(9):4028-32. PubMed ID: 1570328
[TBL] [Abstract][Full Text] [Related]
40. The molecular biology and pyridoxine responsiveness of X-linked sideroblastic anaemia.
May A; Bishop DF
Haematologica; 1998 Jan; 83(1):56-70. PubMed ID: 9542324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]